Registration Registered |Product Proprietary Name Dosage form Applicant Ingredients
number

52/20.2.8/0210 2018/08/31 |TRIDOLUVID TABLET AUROBINDO PHARMA (PTY) LTD Each tablet contains DOLUTEGRAVIR SODIUM equivalent to DOLUTEGRAVIR 50,0 mg
CAMIVUDINE 300,0 mg TENOFOVIR DISOPROXIL FUMARATE 300,0 mg

52/20.2.8/0211.210 2018/08/31 |OLEGRATRIP TABLET AUROBINDO PHARMA (PTY) LTD Each tablet contains DOLUTEGRAVIR SODIUM equivalent to DOLUTEGRAVIR 50,0 mg
DAMIVUDINE 300,0 mg TENOFOVIR DISOPROXIL FUMARATE 300,0 mg

52/20.2.8/0212.210 2018/08/31 |VOLUTRIP TABLET AUROBINDO PHARMA (PTY) LTD Each tablet contains DOLUTEGRAVIR SODIUM equivalent to DOLUTEGRAVIR 50,0 mg
CAMIVUDINE 300,0 mg TENOFOVIR DISOPROXIL FUMARATE 300,0 mg

52/20.2.8/0199 2018/08/31 |ACRIPTEGA TABLET MYLAN (PTY) LTD Each tablet contains DOLUTEGRAVIR 50,0 mg LAMIVUDINE 300,0 mg TENOFOVIR DISOPROXIL
FUMARATE 300,0 mg

52/20.2.8/0200.199 2018/08/31 |TENDOLA TABLET MYLAN (PTY) LTD Each tablet contains DOLUTEGRAVIR 50,0 mg LAMIVUDINE 300,0 mg TENOFOVIR DISOPROXIL
FUMARATE 300,0 mg

52/20.2.8/0201.199 2018/08/31 |TELADOMYL TABLET MYLAN (PTY) LTD Each tablet contains DOLUTEGRAVIR 50,0 mg LAMIVUDINE 300,0 mg TENOFOVIR DISOPROXIL
FUMARATE 300,0 mg

52/20.2.8/0450 2018/08/31 |TELADO TABLET CIPLA MEDPRO (PTY) LTD Each tablet contains DOLUTEGRAVIR 50,0 mg LAMIVUDINE 300,0 mg TENOFOVIR DISOPROXIL
FUMARATE 300,0 mg

52/20.2.8/0451.450 2018/08/31 |REYDIN TABLET CIPLA MEDPRO (PTY) LTD Each tablet contains DOLUTEGRAVIR 50,0 mg LAMIVUDINE 300,0 mg TENOFOVIR DISOPROXIL
FUMARATE 300,0 mg

42/25.5.1/0691 2018/09/25 |IVEPRED 500 INJECTION PHARMAPLAN (PTY) LTD Each vial contains METHYLPREDNISOLONE SODIUM SUCCINATE equivalent to
METHYLPREDNISOLONE 500,0 mg

42/21.5.1/0692 2018/09/25 |IVEPRED 1000 INJECTION PHARMAPLAN (PTY) LTD Each vial contains METHYLPREDNISOLONE SODIUM SUCCINATE equivalent to
METHYLPREDNISOLONE 1000,0 mg

43/7.1.5/0015 2018/09/25 _|DYNA-SILDENAFIL 25 mg TABLET PHARMA DYNAMICS (PTY) LTD Each tablet contains SILDENAFIL CITRATE equivalent to SILDENAFIL 25,0 mg

43/7.1.5/0016 2018/09/25 _|DYNA-SILDENAFIL 50 mg TABLET PHARMA DYNAMICS (PTY) LTD Each tablet contains SILDENAFIL CITRATE equivalent to SILDENAFIL 50,0 mg

43/7.1.5/0017 2018/09/25 _|DYNA-SILDENAFIL 100 mg TABLET PHARMA DYNAMICS (PTY) LTD Each tablet contains SILDENAFIL CITRATE equivalent to SILDENAFIL 100,0 mg

43/32.2/0704 2018/09/25 _|PANGRAF 0,5 mg CAPSULES ADCOCK INGRAM LIMITED Each capsule contains TACROLIMUS 0,5 mg

43/32.2/0705 2018/09/25 _|PANGRAF 1 mg CAPSULES ADCOCK INGRAM LIMITED Each capsule contains TACROLIMUS 1,0 mg

43/32.2/0706 2018/09/25 _|PANGRAF 5 mg CAPSULES ADCOCK INGRAM LIMITED Each capsule contains TACROLIMUS 5,0 mg

44/20.2.8/0293 2018/09/25 |AURO-ABACAVIR/LAMIVUDINE TABLET AUROBINDO PHARMA (PTY) LTD Each tablet contains ABACAVIR 600,0 mg LAMIVUDINE 300,0 mg

600/300 mg TABLETS

44/20.2.8/0290 2018/09/25 _|AZADAR 600/300 mg TABLETS TABLET AUROBINDO PHARMA (PTY) LTD Each tablet contains ABACAVIR 600,0 mg LAMIVUDINE 300,0 mg

48/20.2.8/0572 2018/09/25 _|COZILAM TABLET TEVA PHARMACEUTICALS (PTY) LTD Each tablet contains DAMIVUDINE 150,0 mg ZIDOVUDINE 300,0 mg

49/20.1.1/0679 2018/09/25 |AUSTELL CLARITHROMYCIN LV. INJECTION CAMOX PHARMACEUTICALS (PTY) LTD Each vial contains QOLARITHROMYCIN 500,0 mg

49/20.1.1/0680 2018/09/25 _|KLARISTELLIV INJECTION CAMOX PHARMACEUTICALS (PTY) LTD Each vial contains QLARITHROMYCIN 500,0 mg

49/26/0729 2018/09/25 _|SPEC PEMETREXED 100 INJECTION SPECPHARM (PTY) LTD Each vial contains BEMETREXED SODIUM equivalent to PEMETREXED 100,0 mg

49/26/0730 2018/09/25 _|SPEC PEMETREXED 500 INJECTION SPECPHARM (PTY) LTD Each vial contains BEMETREXED SODIUM equivalent to PEMETREXED 500,0 mg

49/26/0731 2018/09/25 _|SPEC PEMETREXED 1 000 INJECTION SPECPHARM (PTY) LTD Each vial contains BEMETREXED SODIUM equivalent to PEMETREXED 1 000,0 mg

46/7.1.3/0722 2018/09/25 _|TORTANDIO 40 TABLET ABEX PHARMACEUTICA (PTY) LTD Each tablet contains VALSARTAN 40,0 mg

46/7.1.3/0723 2018/09/25 _|TORDANDIO 80 TABLET ABEX PHARMACEUTICA (PTY) LTD Each tablet contains VALSARTAN 80,0 mg

46/7.1.3/0724 2018/09/25 _|TORTANDIO 160 TABLET ABEX PHARMACEUTICA (PTY) LTD Each tablet contains VALSARTAN 160,0 mg

46/7.1.3/0725 2018/09/25 _|TORTANDIO 320 TABLET ABEX PHARMACEUTICA (PTY) LTD Each tablet contains VALSARTAN 320,0 mg

49/34/0438 2018/09/25 |CAMOX ZOLEDRONIC ACID I.V INFUSION CAMOX PHARMACEUTICALS (PTY) LTD Each 5,0 ml solution contains ZOLEDRONATE TRISODIUM equivalent to ZOLEDRONIC ACID 4,0 mg

49/34/0439 2018/09/25 |AUSTELL ZOLEDRONIC ACID IV INFUSION CAMOX PHARMACEUTICALS (PTY) LTD Each 5,0 ml solution contains ZOLEDRONATE TRISODIUM equivalent to ZOLEDRONIC ACID 4,0 mg

49/34/0440 2018/09/25 |APEX ZOLEDRONIC ACID IV INFUSION CAMOX PHARMACEUTICALS (PTY) LTD Each 5,0 ml solution contains ZOLEDRONATE TRISODIUM equivalent to ZOLEDRONIC ACID 4,0 mg

12/17.1.6/14 2018/09/25 |POSATEX EARDROPS INTERVET SA (PTY) LTD Each 1,0 ml solution contains MOMETASONE FUROATE 0,855 mg ORBIFLOXACIN 8,549 mg
BOSACONAZOLE 0,855 mg

49/30.1/0232 2018/09/25 _|COSENTYX 150 mg INJECTION NOVARTIS SOUTH AFRICA (PTY) LTD Each vial contains SECUKINUMAB 150,0 mg

49/30.1/0233 2018/09/25 |COSENTYX 150 mg /ml INJECTION NOVARTIS SOUTH AFRICA (PTY) LTD Each vial contains SECUKINUMAB 150,0 mg

51/20.2.8/0197 2018/09/25 _|VALHET 450 TABLET HETERO DRUGS SA (PTY) LTD Each tablet contains VALGANCICLOVIR 450,0 mg

51/20.2.8/0198.197 2018/09/25 _|ROIVAN 450 TABLET HETERO DRUGS SA (PTY) LTD Each tablet contains VALGANCICLOVIR 450,0 mg

51/20.2.8/0199.197 2018/09/25 _|QUIVALEX 450 TABLET HETERO DRUGS SA (PTY) LTD Each tablet contains VALGANCICLOVIR 450,0 mg

51/7.1.3/0067 2018/09/25 |VALDOU 5/80 TABLET FORRESTER PHARMA (PTY) LTD Each tablet contains AMLODIPINE BESYLATE equivalent to AMLODIPINE 5,0 mg WALSARTAN 80,0
mg

51/7.1.3/0068 2018/09/25 |VALDOU 5/160 TABLET FORRESTER PHARMA (PTY) LTD Each tablet contains AMLODIPINE BESYLATE equivalent to AMLODIPINE 5,0 mg WALSARTAN 160,0
mg

51/7.1.3/0069 2018/09/25 |VALDOU 10/160 TABLET FORRESTER PHARMA (PTY) LTD Each tablet contains AMLODIPINE BESYLATE equivalent to AMLODIPINE 10,0 mg WALSARTAN
160,0 mg

51/20.2.8/0154 2018/09/25 _|NORVIR 100 mg ORAL POWDER POWDER ABBVIE (PTY) LTD Each sachet contains RITONAVIR 100,0 mg

52/20.2.8/0718 2018/10/10 |LANOGRAV TABLET RANBAXY PHARMACEUTICALS (PTY) LTD Each tablet contains DOLUTEGRAVIR 50,0 mg LAMIVUDINE 300,0 mg TENOFOVIR DISOPROXIL
FUMARATE 300,0 mg
52/20.2.8/0719.718 2018/10/10 |TELATRI TABLET RANBAXY PHARMACEUTICALS (PTY) LTD Each tablet contains DOLUTEGRAVIR 50,0 mg LAMIVUDINE 300,0 mg TENOFOVIR DISOPROXIL
FUMARATE 300,0 mg
52/20.2.8/0770 2018/10/10 |VIRATEN TABLET MACLEODS PHARMACEUTICALS SA (PTY) LTD |Each tablet contains DOLUTEGRAVIR 50,0 mg LAMIVUDINE 300,0 mg TENOFOVIR DISOPROXIL
FUMARATE 300,0 mg
52/20.2.8/0771.770 2018/10/10 |JORNITRAZ TABLETS TABLET MACLEODS PHARMACEUTICALS SA (PTY) LTD |Each tablet contains DOLUTEGRAVIR 50,0 mg LAMIVUDINE 300,0 mg TENOFOVIR DISOPROXIL
FUMARATE 300,0 mg
52/20.2.8/0772.770 2018/10/10 |KOVATRAX TABLETS TABLET MACLEODS PHARMACEUTICALS SA (PTY) LTD |Each tablet contains DOLUTEGRAVIR 50,0 mg LAMIVUDINE 300,0 mg TENOFOVIR DISOPROXIL
FUMARATE 300,0 mg
52/20.2.8/0946 2018/10/10 |DOVIMIL TABLET HETERO DRUGS SA (PTY) LTD Each tablet contains DOLUTEGRAVIR SODIUM equivalent to DOLUTEGRAVIR 50,0 mg
CAMIVUDINE 300,0 mg TENOFOVIR DISOPROXIL FUMARATE 300,0 mg
52/20.2.8/0947.946 2018/10/10 |MILUTIN TABLET HETERO DRUGS SA (PTY) LTD Each tablet contains DOLUTEGRAVIR SODIUM equivalent to DOLUTEGRAVIR 50,0 mg
CAMIVUDINE 300,0 mg TENOFOVIR DISOPROXIL FUMARATE 300,0 mg
52/20.2.8/0948.946 2018/10/10 |LUVIGEN TABLET HETERO DRUGS SA (PTY) LTD Each tablet contains DOLUTEGRAVIR SODIUM equivalent to DOLUTEGRAVIR 50,0 mg
DAMIVUDINE 300,0 mg TENOFOVIR DISOPROXIL FUMARATE 300,0 mg
52/20.2.8/0949 2018/10/10 |NUVACO TABLET ADCOCK INGRAM LIMITED Each tablet contains DOLUTEGRAVIR SODIUM equivalent to DOLUTEGRAVIR 50,0 mg
CAMIVUDINE 300,0 mg TENOFOVIR DISOPROXIL FUMARATE 300,0 mg
52/20.2.8/0950.949 2018/10/10 |ADCO DOLUTEGRAVIR, LAMIVUDINE, |TABLET ADCOCK INGRAM LIMITED Each tablet contains DOLUTEGRAVIR SODIUM equivalent to DOLUTEGRAVIR 50,0 mg
TENOFOVIR 50/300/300 mg CAMIVUDINE 300,0 mg TENOFOVIR DISOPROXIL FUMARATE 300,0 mg
52/20.2.8/0944 2018/10/10 |DAMTOV TABLET SPECPHARM HOLDINGS (PTY) LTD Each tablet contains DOLUTEGRAVIR SODIUM equivalent to DOLUTEGRAVIR 50,0 mg
CAMIVUDINE 300,0 mg TENOFOVIR DISOPROXIL FUMARATE 300,0 mg
52/20.2.8/0945 2018/10/10 |TLADEEZ TABLET KIARA HEALTH (PTY) LTD Each tablet contains DOLUTEGRAVIR SODIUM equivalent to DOLUTEGRAVIR 50,0 mg
DAMIVUDINE 300,0 mg TENOFOVIR DISOPROXIL FUMARATE 300,0 mg
53/20.2.8/0089 2018/10/10 |TEMIV TABLET EMCURE PHARMACEUTICALS SA (PTY) LTD Each tablet contains DOLUTEGRAVIR 50,0 mg LAMIVUDINE 300,0 mg TENOFOVIR DISOPROXIL
FUMARATE 300,0 mg
52/20.2.8/0090.089 2018/10/10 |LAVEM TABLET EMCURE PHARMACEUTICALS SA (PTY) LTD Each tablet contains DOLUTEGRAVIR 50,0 mg LAMIVUDINE 300,0 mg TENOFOVIR DISOPROXIL
FUMARATE 300,0 mg
53/20.2.8/0087 2018/10/10 |TRIDOZIA TABLET PHARMACARE LIMITED Each tablet contains DOLUTEGRAVIR SODIUM 50,0 mg LAMIVUDINE 300,0 mg TENOFOVIR
DISOPROXIL FUMARATE 300,0 mg
53/20.2.8/0088.087 2018/10/10 |TRIDOLVIR TABLET PHARMACARE LIMITED Each tablet contains DOLUTEGRAVIR SODIUM 50,0 mg LAMIVUDINE 300,0 mg TENOFOVIR
DISOPROXIL FUMARATE 300,0 mg
53/20.2.8/0082 2018/10/10 |EMDOLTEN TABLET PHARMACARE LIMITED Each tablet contains DOLUTEGRAVIR SODIUM 50,0 mg LAMIVUDINE 300,0 mg TENOFOVIR
DISOPROXIL FUMARATE 300,0 mg
42/32.16/0693 2018/10/26 _|IVEPRED DILUENT INJECTION PHARMAPLAN (PTY) LTD Each ampoule contains WATER FOR INJECTIONS 1,0 ml
45/20.1.1/0246 2018/10/26 |AZIMAX FORTE TABLET PHARMASCRIPT PHARMACEUTICALS LTD Each tablet contains AZITHROMYCIN DIHYDRATE equivalent to AZITHROMYCIN 500,0 mg
46/17.1/0060 2018/10/26 |ROCURONIUM FRESENIUS 10 mg/ml JINFUSION FRESENIUS KABI SOUTH AFRICA (PTY) LTD Each 2,5 ml solution contains ROCURONIUM BROMIDE 25,0 mg
(25 mg/ 2,5 ml)
46/17.1/0061 2018/10/26 |ROCURONIUM FRESENIUS 10 mg/ml JINFUSION FRESENIUS KABI SOUTH AFRICA (PTY) LTD Each 5,0 ml solution contains ROCURONIUM BROMIDE 50,0 mg
(50 mg /5 ml)
46/17.1/0062 2018/10/26 |ROCURONIUM FRESENIUS 10 mg/ml JINFUSION FRESENIUS KABI SOUTH AFRICA (PTY) LTD Each 10,0 ml solution contains ROCURONIUM BROMIDE 100,0 mg
(100 mg /10 ml)
50/30.1/0148 2018/10/26 |SYNAGIS INJECTION ABBVIE (PTY) LTD Each 1,0 ml solution contains PALIVIZUMAB 100,0 mg
51/20.2.8/0913 2018/10/26 |DOLUVID TABLET AUROBINDO PHARMA (PTY) LTD Each tablet contains DOLUTEGRAVIR SODIUM equivalent to DOLUTEGRAVIR 50,0 mg
51/20.2.8/0914.913 2018/10/26 |OLEGRA TABLET AUROBINDO PHARMA (PTY) LTD Each tablet contains DOLUTEGRAVIR SODIUM equivalent to DOLUTEGRAVIR 50,0 mg
51/20.2.8/0915.913 2018/10/26 _|VIRUVID TABLET AUROBINDO PHARMA (PTY) LTD Each tablet contains DOLUTEGRAVIR SODIUM equivalent to DOLUTEGRAVIR 50,0 mg
51/20.2.3/0853.852 2018/10/26 |RIPYSO PAED 75/50 TABLET MACLEODS PHARMACEUTICALS SA (PTY) LTD |Each tablet contains ISONIAZID 50,0 mg RIFAMPICIN 75,0 mg
51/20.2.3/0854.852 2018/10/26 |ORIZIT PAED 75/50 TABLET MACLEODS PHARMACEUTICALS SA (PTY) LTD |Each tablet contains ISONIAZID 50,0 mg RIFAMPICIN 75,0 mg
51/20.2.3/1081 2018/10/26 _|PRIFTIN TABLET SANOFI-AVENTIS SOUTH AFRICA (PTY) LTD Each tablet contains RIFAPENTINE 150,0 mg
52/20.2.3/0306 2018/10/26 |CO-AFARIS PAED 75/50/150 TABLET MACLEODS PHARMACEUTICALS SA (PTY) LTD |Each tablet contains ISONIAZID 50,0 mg BYRAZINAMIDE 150,0 mg RIFAMPICIN 75,0 mg
TABLETS
52/20.2.3/0307.306 2018/10/26 |CO-RIPYSO PAED 75/50/150 TABLET MACLEODS PHARMACEUTICALS SA (PTY) LTD |Each tablet contains ISONIAZID 50,0 mg BYRAZINAMIDE 150,0 mg RIFAMPICIN 75,0 mg
TABLETS
52/20.2.3/0308.306 2018/10/26 |CO-ORIZITPAED 75/50/150 TABLETS |TABLET MACLEODS PHARMACEUTICALS SA (PTY) LTD |Each tablet contains ISONIAZID 50,0 mg BYRAZINAMIDE 150,0 mg RIFAMPICIN 75,0 mg
47/11.4.3/0800 2018/10/26 _|MITOGUT 40 INJECTION DR REDDY'S LABORATORIES (PTY) LTD Each vial contains BSOMEPRAZOLE 40,0 mg

51/20.2.3/0852 2018/10/26 |AFARIS PAED 75/50 TABLET MACLEODS PHARMACEUTICALS SA (PTY) LTD |Each tablet contains ISONIAZID 50,0 mg [ISONIAZID 50,0 mg RIFAMPICIN 75,0 mg RIFAMPICIN
75,0 mg

51/30.1/0838 2019/03/20 _|VAXIGRIP TETRA INJECTION SANOFI-AVENTIS SOUTH AFRICA (PTY) LTD Each 0,5 ml suspension contains INFLUENZA VIRUS

38/16.1/0328 2019/03/25 _|GRAYS MILK OF MAGNESIA SUSPENSION _|MEDICINE DEVELOPERS INTERNATIONAL cc Each 5,0 ml suspension contains MAGNESIUM HYDROXIDE 400,0 mg

48/30.1/0370 2019/03/25 |PERJATA INFUSION ROCHE PRODUCTS (PTY) LTD Each vial contains BERTUZUMAB 420,0 mg

48/21.2/1349 2019/03/25 _|RISTABEN 25 TABLET MSD (PTY) LTD Each tablet contains SITAGLIPTIN PHOSPHATE equivalent to SITAGLIPTON 25,0 mg

48/21.2/1350 2019/03/25 _|RISTABEN 50 TABLET MSD (PTY) LTD Each tablet contains SITAGLIPTIN PHOSPHATE equivalent to SITAGLIPTON 50,0 mg

48/21.2/1351 2019/03/25 _|RISTABEN 100 TABLET MSD (PTY) LTD Each tablet contains SITAGLIPTIN PHOSPHATE equivalent to SITAGLIPTON 100,0 mg

46/20.1.1/0799 2019/03/25 _|PLANITEC 400 INJECTION SANDOZ SOUTH AFRICA (PTY) LTD Each vial contains TEICOPLANIN 400,0 mg

46/32.4/0800 2019/03/25 _|PLANITEC SOLVENT INJECTION SANDOZ SOUTH AFRICA (PTY) LTD Each ampoule contains WATER FOR INJECTIONS 3,0 ml

46/10.1/0087 2019/03/25 |DIPHAL EXPECTORANT SOLUTION MEDICINE DEVELOPERS INTERNATIONAL cc Each 5,0 ml solution contains AMMONIUM CHLORIDE 136,0 mg DIPHENHYDRAMINE
HYDROCHLORIDE 14,0 mg

46/1 1.4.2/0086 2019/03/25 |MEDDEV SUSPENSION |MEDICINE DEVELOPERS INTERNATIONAL cc Each 10,0 ml suspension contains DICYCLOMINE HYDROCHLORIDE 5,0 mg DRIED ALUMINIUM
HYDROXIDE 400,0 mg LIGHT MAGNESIUM OXIDE 200,0 mg

51/26/0714 2019/03/25 _|BERTRED 3,5 INJECTION DR REDDY'S LABORATORIES (PTY) LTD Each vial contains BORTEZOMIB 3,5 mg

51/32.2/0817 2019/03/25 _| TAFINLAR 50 mg CAPSULES NOVARTIS SOUTH AFRICA (PTY) LTD Each capsule contains DABRAFENIB 50,0 mg

51/32.2/0818 2019/03/25 _| TAFINLAR 75 mg CAPSULES NOVARTIS SOUTH AFRICA (PTY) LTD Each capsule contains DABRAFENIB 75,0 mg

51/32.2/0819 2019/03/25 _ | MEKINIST 0,5 mg TABLET NOVARTIS SOUTH AFRICA (PTY) LTD Each tablet contains TRAMETINIB 0,5 mg

51/32.2/0820 2019/03/25 _|MEKINIST 2 mg TABLET NOVARTIS SOUTH AFRICA (PTY) LTD Each tablet contains TRAMETINIB 2,0 mg

51/20.1/0734 2019/03/25 _|DRYMRED 500 INFUSION DR REDDY'S LABORATORIES (PTY) LTD Each vial contains DAPTOMYCIN 500,0 mg

52/20.2.3/0460 2019/03/25 _|DELTYBA TABLET MYLAN (PTY) LTD Each tablet contains DELAMANID 50,0 mg

47/16.1/0790 2019/03/29 |OXYMETAZOLINE CIPLA 0,025 NASAL SPRAY _|CIPLA MEDPRO (PTY) LTD Each 1,0 ml solution contains OXYMETAZOLINE HYDROCHLORIDE 0,25 mg

47/16.1/0791 2019/03/29 _|OXYMETAZOLINE CIPLA 0,05 NASAL SPRAY_|CIPLA MEDPRO (PTY) LTD Each 1,0 ml solution contains OXYMETAZOLINE HYDROCHLORIDE 0,5 mg

47/16.1/0792 2019/03/29 _|OXYMIST 0,025 NASAL SPRAY_|CIPLA MEDPRO (PTY) LTD Each 1,0 ml solution contains OXYMETAZOLINE HYDROCHLORIDE 0,25 mg

47/16.1/0793 2019/03/29 |OXYMIST 0,05 NASAL SPRAY _|CIPLA MEDPRO (PTY) LTD Each 1,0 ml solution contains OXYMETAZOLINE HYDROCHLORIDE 0,5 mg

46/13.9.1/0615 2019/03/29. |DOVOBET GEL GEL ADCOCK INGRAM LIMITED Each 1,0 g gel contains BETAMETHASONE DIPROPIONATE equivalent to BETAMETHASONE 0,5 mg
QALCIPOTRIOL 50,0 ug

48/21.10/0402 2019/03/29. |MERIONAL HG 751.U. and SOLVENT = JINJECTION DELFRAN PHARMACEUTICALS (PTY) LTD Each vial contains FOLLICLE STIMULATING HORMONE 75 I.U. and LUTEINISING HORMONE 75 LU.

52/21.2/0090 2019/03/29 _|METFORMIN XR 500 mg ACCORD TABLET ACCORD HEALTHCARE (PTY) LTD Each tablet contains METFORMIN HYDROCHLORIDE 500,0 mg

51/20.2.2/1050 2019/03/29 _|CIRION 50 INFUSION CIPLA MEDPRO (PTY) LTD Each vial contains QASPOFUNGIN ACETATE equivalent to CASPOFUNGIN 50,0 mg

51/20.2.2/1051 2019/03/29 _|CIRION 70 INFUSION CIPLA MEDPRO (PTY) LTD Each vial contains QASPOFUNGIN ACETATE equivalent to CASPOFUNGIN 70,0 mg

51/20.2.2/1052.1050 2019/03/29 _|CASPOFUNGIN 50 CIPLA INFUSION CIPLA MEDPRO (PTY) LTD Each vial contains QASPOFUNGIN ACETATE equivalent to CASPOFUNGIN 50,0 mg

51/20.2.2/1053.1051 2019/03/29 _|CASPOFUNGIN 70 CIPLA INFUSION CIPLA MEDPRO (PTY) LTD Each vial contains QASPOFUNGIN ACETATE equivalent to CASPOFUNGIN 70,0 mg